Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Scientific Reports
|
July 11, 2015
Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer
Daniel H Ahn, Junan Li, Lai Wei, et al.
Leukemia & Lymphoma
|
August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
Alison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Cancer
|
April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group
Jan C Buckner, Joel M Reid, Keith Wright, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2013
Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
Amita Patnaik, Kyriakos P Papadopoulos, Anthony W Tolcher, et al.
Stem Cells and Development
|
February 17, 2021
Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro
Jeroen van de Peppel, Gerben J Schaaf, Adriana Arruda Matos, et al.
The Journal of Rheumatology
|
November 16, 2001
A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis
R H Derijk, M J Schaaf, G Turner, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Journal of the Neurological Sciences
|
December 2, 2000
Comparison of serum S-100 protein levels following stroke and traumatic brain injury
J W Elting, A E de Jager, A W Teelken, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2005
Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries
Gerben J Schaaf, Jan M Ruijter, Fred van Ruissen, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Scientific Reports
|
July 11, 2015
Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer
Daniel H Ahn, Junan Li, Lai Wei, et al.
Leukemia & Lymphoma
|
August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
Alison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Cancer
|
April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group
Jan C Buckner, Joel M Reid, Keith Wright, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 2013
Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
Amita Patnaik, Kyriakos P Papadopoulos, Anthony W Tolcher, et al.
Stem Cells and Development
|
February 17, 2021
Cell Surface Glycoprotein CD24 Marks Bone Marrow-Derived Human Mesenchymal Stem/Stromal Cells with Reduced Proliferative and Differentiation Capacity In Vitro
Jeroen van de Peppel, Gerben J Schaaf, Adriana Arruda Matos, et al.
The Journal of Rheumatology
|
November 16, 2001
A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis
R H Derijk, M J Schaaf, G Turner, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Journal of the Neurological Sciences
|
December 2, 2000
Comparison of serum S-100 protein levels following stroke and traumatic brain injury
J W Elting, A E de Jager, A W Teelken, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer
Albert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2005
Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries
Gerben J Schaaf, Jan M Ruijter, Fred van Ruissen, et al.
Page
of 10